# AbbVie Inc. (ABBV) FY2026 Q2 Balance Sheet

- Company: AbbVie Inc. (ABBV)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-03, accession number 0001551152-26-000026
- Page: https://plicit.ai/financials/abbv/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/abbv-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 135,115,000,000 US dollars
- **Current assets**: 33,669,000,000 US dollars
- **Non-current assets**: 101,446,000,000 US dollars
- **Liabilities (calculated)**: 141,003,000,000 US dollars
- **Current liabilities**: 41,642,000,000 US dollars
- **Non-current liabilities**: 99,361,000,000 US dollars
- **Equity**: negative 5,888,000,000 US dollars
- **Noncontrolling interest**: 47,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 13,824,000,000 US dollars
- **Prepaid expenses and other**: 8,149,000,000 US dollars
- **Cash and equivalents**: 6,569,000,000 US dollars
- **Inventories**: 5,127,000,000 US dollars
- **Intangible assets, net**: 49,139,000,000 US dollars
- **Goodwill**: 35,519,000,000 US dollars
- **Other assets**: 10,726,000,000 US dollars
- **Property and equipment, net**: 5,796,000,000 US dollars
- **Investments**: 266,000,000 US dollars
- **Accounts payable and accrued liabilities**: 33,301,000,000 US dollars
- **Current portion of long-term debt**: 8,341,000,000 US dollars
- **Short-term borrowings**: 0 US dollars
- **Long-term debt**: 62,481,000,000 US dollars
- **Other long-term liabilities**: 34,603,000,000 US dollars
- **Deferred income taxes**: 2,277,000,000 US dollars
- **Additional paid-in capital**: 23,156,000,000 US dollars
- **Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,844,174,521 shares issued as of June 30, 2026 and 1,838,678,628 as of December 31, 2025**: 18,000,000 US dollars
- **Noncontrolling interest**: 47,000,000 US dollars
- **Accumulated deficit**: negative 17,333,000,000 US dollars
- **Common stock held in treasury, at cost, 77,105,240 shares as of June 30, 2026 and 70,802,593 as of December 31, 2025**: negative 10,618,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,158,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.